EUVIMEDEUVIMED entdecken
Open Access

Cardiac Reverse Remodeling and Changes in Heart Failure Indices After Transcatheter Tricuspid Valve Replacement in Adults With Congenital Heart Disease

Abdalla A Salama, Omar A Abozied, Jason H Anderson, William R Miranda iD, Heidi M Connolly iD, Charles Jain, Allison Cabalka iD, Alexander C Egbe iD

Circulation: Cardiovascular Interventions · 2024

DOI: 10.1161/circinterventions.123.013334 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2024. Verfasst von Abdalla A Salama und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic Rochester, MN (A.A.S., O.A.A., J.H.A., W.R.M., H.M.C., C.J., A.C., A.C.E.). Hauptthemen laut MEDLINE: End Stage Liver Disease, Heart Valve Prosthesis Implantation, Tricuspid Valve Insufficiency, Heart Defects, Congenital. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There are limited data about changes in cardiac function (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR). The purpose of this study was to evaluate cardiac reverse remodeling and temporal changes in heart failure indices after TT-VIVR in adults with congenital heart disease. METHODS: Retrospective cohort study of adults with congenital heart disease that underwent TT-VIVR and had >6 months of follow-up (January 1, 2011, to April 30, 2023). Echocardiographic indices of cardiac remodeling and heart failure indices (New York Heart Association class, NT-proBNP (N-terminal pro-brain natriuretic peptide), glomerular filtration rate, and model for end-stage liver disease excluding international normalized ratio score) were assessed preintervention and at 1-, 3-, and 5-year postintervention. RESULTS: Of 39 patients (age 39 [32–46] years), 14 (36%) and 25 (64%) received Melody valve and Sapien valve prosthesis, respectively. At 1-year post-TT-VIVR, there was a temporal improvement in right atrial reservoir strain (17±8% versus 22±8%, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

End Stage Liver DiseaseHeart Valve Prosthesis ImplantationTricuspid Valve InsufficiencyHeart Defects, CongenitalHeart FailureAdultHumansTricuspid ValveRetrospective StudiesTreatment OutcomeSeverity of Illness Index

Stichwörter der Autor:innen

congenital heart diseaseglobal longitudinal strainglomerular filtration ratereoperationtricuspid valve

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Mayo Clinic Rochester, MN (A.A.S., O.A.A., J.H.A., W.R.M., H.M.C., C.J., A.C., A.C.E.).
  • Department of Cardiovascular Diseases, Suez Canal University, Ismailia, Egypt (A.A.S.).

ORCID-Profile: William R Miranda, Heidi M Connolly, Allison Cabalka, Alexander C Egbe

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Salama, A. A., Abozied, O. A., Anderson, J. H., Miranda, W. R., Connolly, H. M., Jain, C., Cabalka, A., & Egbe, A. C. (2024). Cardiac Reverse Remodeling and Changes in Heart Failure Indices After Transcatheter Tricuspid Valve Replacement in Adults With Congenital Heart Disease. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.123.013334

Vancouver

Salama AA, Abozied OA, Anderson JH, Miranda WR, Connolly HM, Jain C, et al. Cardiac Reverse Remodeling and Changes in Heart Failure Indices After Transcatheter Tricuspid Valve Replacement in Adults With Congenital Heart Disease. Circulation: Cardiovascular Interventions. 2024. doi:10.1161/circinterventions.123.013334

BibTeX
@article{Salama2024,
  author = {Salama, Abdalla A and Abozied, Omar A and Anderson, Jason H and Miranda, William R and Connolly, Heidi M and Jain, Charles and Cabalka, Allison and Egbe, Alexander C},
  title = {Cardiac Reverse Remodeling and Changes in Heart Failure Indices After Transcatheter Tricuspid Valve Replacement in Adults With Congenital Heart Disease},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2024},
  doi = {10.1161/circinterventions.123.013334}
}
Kostenlos starten →